Oct 30, 2024 / 12:00PM GMT
Operator
Thank you for standing by. At this time, I'd like to welcome everyone to Arvinas's third-quarter 2024 earnings call. All lines have been placed on mute to prevent any background noise. (Operator Instructions)
I will now turn the conference over to Jeff Boyle. Please go ahead.
Jeff Boyle - Arvinas Inc - VP - IR
Good morning, everyone, and thank you for joining us. Earlier today, we issued a press release with our third-quarter 2024 financial results and a corporate update which can be accessed in the Investors section of our [email protected].
Joining the call today are John Houston, Arvinas's Chief Executive Officer, President, and Chairperson; Noah Berkowitz, Chief Medical Officer; and Andrew Saik, Chief Financial Officer. Angela Cacace, our Chief Scientific Officer, will join for the Q&A portion of the call.
Before we begin, I want to remind you that today's discussion will contain forward-looking statements that involve risks, uncertainties, and assumptions. These factors are outlined in today's press release and in the
Q3 2024 Arvinas Inc Earnings Call Transcript
Oct 30, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers